OpenVSafe by OpenVAERS
Search V-safe

59C-28542-68261

3 vaccinations 3 coded responses 34 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
402 / KY
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Registered in v-safe
  2. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-20
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-10
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-01-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-01-31
  22. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-11-01
    Dose 3 — Pfizer-BioNTech
  28. 2021-11-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school
    Adult check-in
  29. 2021-11-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  30. 2021-11-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  31. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-11-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-29
    Survey response — day 28, dose 3
    MedDRA: Nasopharyngitis — Feeling: Good
    Free text: Cold
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-12-09
    Survey response — day 35, dose 3
    MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Fair
    Free text: Cough, cold, congestion
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-31
    Survey response — 3 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: Covid-19
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-05-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-11-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-10Pfizer-BioNTech
32021-11-01Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-11 Unsuccessful

Free text

Release 10 — day 28, dose 3

2021-11-29

Symptoms: Cold

Release 10 — day 35, dose 3

2021-12-09

Symptoms: Cough, cold, congestion

Release 11 — 3 months, dose 3

2022-01-31

Symptoms: Covid-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…